Agha-Hosseini et al., 2016Agha-Hosseini F, Sheykhbahaei N. A new approach to the management of caliber-persistent artery: A case report and analysis of previously reported cases. Int J Dermatol. 2016;55(1):11-6.
|
CPLA |
Triamcinolone 40 mg/mL |
|
3 |
2 w |
Complete regression |
6 m |
none |
Buckmiller, Francis, Glade, 2008Buckmiller LM, Francis CL, Glade RS. Intralesional steroid injection for proliferative parotid hemangiomas. Int J Pediatr Otorhinolaryngol. 2008;72(1):81-7.
|
hemangiomas |
Triamcinolone and betamethasone |
40 and 6 mg/cm3
|
1-3 |
6-25 w (12 w) |
11 lesions complete resolution |
6 m |
4 Patients failure to thrive |
Meeuwis et al., 1990Meeuwis J, Bos C, Hoeve L, Van Der Voort E. Subglottic hemangiomas in infants: treatment with intralesional corticosteroid injection and intubation. Int J Pediatr Otorhinolaryngol. 1990;19(2):145-150.
|
hemangiomas |
Methylprednisolone |
20-40 mg |
1-5 |
|
Complete regression . |
6 m to5 y |
Pneumonia, slight growth, acne Retardation, and fluffy Hair growt |
Farmand, Kuttengerg, 1996Farmand M, Kuttenberger JJ. A new therapeutic concept for the treatment of cystic hygroma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81(4):389-395.
|
lymphangioma |
Triamcinolone (instilled through the suction drain) |
10 mg/kg (30-160 mg) |
1-2 |
|
completely disappeared in 1 case, residual tumor excised |
1-4 y |
None |
Luo, Gan, 2013Luo Q-F, Gan Y-H. Pingyangmycin with triamcinolone acetonide effective for treatment of lymphatic malformations in the oral and maxillofacial region. J Craniomaxillofac Surg. 2013;41(4):345-9.
|
lymphatic malformations |
Triamcinolone acetonide (50 mg/5 mL) + Pingyangmycin 0.625 mg/mL |
5 mL |
8 |
2e4 weeks |
pingyangmycin with triamcinolone was more effective than pingyangmycin alone |
- |
None |
Parisi, Glick, Glick, 2006Parisi E, Glick P, Glick M. Recurrent intraoral pyogenic granuloma with satellitosis treated with corticosteroids. Oral Dis. 2006;12(1):70-72.
|
PG |
Triamcinolone 40 mg/mL |
(0.1 mL with 0.5 mL of 0.5% bupivicaine |
6 |
1 & 2 inj weekly, and 4 inj bi-weekly |
90% resolved |
10 w |
None |
De La Rosa García, 2006De La Rosa-Garcia E, Bologna-Molina R, Vega-González M, De Jesus T. Graft-versus-host disease, an eight case report and literature review. Med Oral Patol Oral Cir Bucal. 2006;11(6):E486-92.
|
PG |
Triamcinolone |
5 mg |
3 |
- |
complete resolution |
- |
none |
Adenis-Lamarre et al., 2009Adenis-Lamarre E, Fricain J, Tabrizi R, Turlure P, Milpied N, Beylot-Barry M. Massive pyogenic granuloma of the oral cavity during chronic graft-versus-host disease: treatment with local triamcinolone injection. Ann Dermatol Venereol. 2009;136(11):818-20.
|
PG |
Triamcinolone |
|
|
|
|
|
|
Dolanmaz et al., 2016Dolanmaz D, Esen A, Mihmanlı A, Işık K. Management of central giant cell granuloma of the jaws with intralesional steroid injection and review of the literature. Oral Maxillofac Surg. 2016;20(2):203-9.
|
CGCG |
Triamcinolone + 0.5 % marcaine + epinephrine |
3.5 mL |
6 |
Weekly |
4 complete resolution, 2 Partial recovery, 1 did not response |
39 m |
None |
Nogueira et al., 2010Nogueira R, Teixeira R, Cavalcante R, Ribeiro R, Rabenhosrt S. Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases. Int J Oral Maxillofac Surg. 2010;39(12):1204-1210.
|
CGCG |
Triamcinolone (20 mg/mL) + 2% lidocaine |
0.1 mL/cm3
|
6 |
bweekly |
15 complete resolution, 4 Partial recovery, 2 did not response |
4-8 y |
None |
Sezer et al., 2005Sezer B, Koyuncu B, Gomel M, Gunbay T. Intralesional corticosteroid injection for central giant cell granuloma: a case report and review of the literature. Turk J Pediatr. 2005;47(1):75-81.
|
CGCG |
Triamcinolone (10 mg/mL) + lidocaine 2% |
4 mL |
6 |
Weekly |
complete resolution |
3 Y |
None |
Da Silva Sampieri et al., 2013Da Silva Sampieri MB, Yaedú RYF, Santos PSS, Goncales ES, Santa’ana E, Consolaro A, Cardoso LB. Central giant cell granuloma: treatment with calcitonin, triamcinolone acetonide, and a cystic finding 3 years and 6 months after the primary treatment. Oral Maxillofac Surg. 2013;17(3):229-34.
|
CGCG |
Triamcinolone + Articaine |
2 mL |
6 |
Weekly |
complete resolution |
3 Y |
None |
Carlos, Sedano, 2002Carlos R, Sedano HO. Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93(2):161-166.
|
CGCG |
Triamcinolone (10 mg/mL, + Lidocaine 2% orBupivacaine 50% |
3-6 mL |
4-20 |
every 15 days- every 3 weeks |
complete resolution |
2-7 y |
None |
Haldar, 1976Haldar B. Cheilitis glandularis treated by injection of intralesional triamcinolone. Indian J Dermatol. 1976;21(3):53-4.
|
Cheilitis glandularis |
Triamcinolone 1.5 mg/mL |
2 to 3 mg in 10 to 15 Places |
10 |
4 weekly and 2 biweekly, 2 monthly, 2 bimonthly |
complete resolution |
8 m |
None |
Sugaya, Migliari, 2018Sugaya N, Migliari D. Cheilitis glandularis of both lips: successful treatment with a combination of an intralesional steroid injection and tacrolimus ointment. Case Rep Dent. 2018;2018:9169208.
|
Cheilitis glandularis |
10 mg triamcinolone suspension 0.1% tacrolimus ointment) |
|
2 |
Monthly
Twice daily, 2 w |
completely resolving |
1 y |
None |
Samiee, 2011Samiee A, Sabzerou D, Edalatpajouh F, Clark GT, Ram S. Temporomandibular joint injection with corticosteroid and local anesthetic for limited mouth opening. J Oral Sci. 2011;53(3):321-325.
|
TMD |
Triamcinolone acetonide, 40 mg/mL |
0/5 mL |
1 |
- |
reduced signs and symptoms |
1 w |
temporary facial palsy |
Stoll et al., 2012Stoll ML, Good J, Sharpe T, Beukelman T, Young D, Waite PD, Cron RQ. Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritis. J Oral Maxillofac Surg. 2012;70(8):1802-1807.
|
TMD |
Triamcinolone hexacetonide, 20 mg/mL |
0/5-1 mL |
1 |
- |
reduced signs and symptoms |
0.5 - 23 m |
None |
Alstergren et al., 1996Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. The effect on joint fluid concentration of neuropeptide Y by intraarticular injection of glucocorticoid in temporomandibular joint arthritis. Acta Odontol Scand. 1996;54(1):1-7.
|
TMD |
methylprednisolone 40 mg/mL + lidocaine |
0/5-0/7 mL |
1 |
- |
reduced signs and symptoms and NPY-LI |
6 w |
None |
Bjørnland, Gjaerum, Møystad, 2007Bjørnland T, Gjaerum A, Møystad A. Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injection compared with injection with sodium hyaluronate. J Oral Rehabil. 2007;34(8):583-9.
|
TMD |
Betamethasone sodium phosphate+ acetate |
0/7-1 mL |
2 |
Biweekly |
reduce pain and improve function |
6 m |
Temporary pain after injections |
Lee et al., 2013Lee S-H, Yoon H-J. Intralesional infiltration of corticosteroids in the treatment of localized Langerhans cell histiocytosis of the mandible: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(4):e255-60.
|
Langerhans cell histiocytosis |
methylprednisolone, 40 mg/mL |
3 mL |
1 |
- |
complete resolution |
35 mo |
None |
Milián, 2001Milián MA, Bagán JV, Jiménez Y, Pérez A, Scully C, Antoniades D. Langerhans’ cell histiocytosis restricted to the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(1):76-9.
|
Langerhans cell histiocytosis |
Triamcinolone acetonide |
25 mg |
8 |
every 3 weeks |
complete resolution |
1 y |
none |
Esen et al., 2010Esen A, Dolanmaz D, Kalaycı A, Gunhan Ö, Avunduk MC. Treatment of localized Langerhans’ cell histiocytosis of the mandible with intralesional steroid injection: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(2):e53-8.
|
Langerhans cell histiocytosis |
methylprednisolone succinate (40 mg/mL) |
2 mL |
3 |
Every 4 month |
Near-complete resolution |
36 m |
None |
Putters et al., 2005Putters TF, De Visscher J, Van Veen A, Spijkervet F. Intralesional infiltration of corticosteroids in the treatment of localised langerhans’ cell histiocytosis of the mandible: Report of known cases and three new cases. Int J Oral And Maxillofac Surg. 2005;34(5):571-575.
|
Langerhans cell histiocytosis |
methylprednisolone succinate (40 mg/mL) |
1-2 mL |
1 |
- |
complete resolution |
9 y |
None |
Graham, Barret, Goltz, 1999Graham BS, Barrett TL, Goltz RW. Nodular fasciitis: response to intralesional corticosteroids. J Am Acad Dermatol. 1999;40(3):490-492.
|
Nodular fasciitis |
Triamcinolone acetonide (10mg/mL) |
1.5 mL. |
1 |
- |
completeresolution |
1 y |
None |
Kaplan, 2012Kaplan I, Alterman M, Kleinman S, Reiser V, Shuster A, Dagan Y, Shlomi B. The clinical, histologic, and treatment spectrum in necrotizing sialometaplasia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(5):577-85.
|
necrotizing sialometaplasia |
Dexamethasone+ 2% lidocaine |
10 mg |
1 |
- |
The lesion got worsen. |
1 w |
None |
Keogh et al., 2004Keogh P, O’regan E, Toner M, Flint S. Necrotizing sialometaplasia: an unusual bilateral presentation associated with antecedent anaesthesia and lack of response to intralesional steroids. Case report and review of the literature. Br Dent J. 2004;196(2):79-81.
|
necrotizing sialometaplasia |
Triamcinolone |
10 mg |
3 |
Weekly |
There was no difference in the rate of healing |
1 m |
None |
Picciani et al., 2010Picciani BLS, Silva-Junior GO, Barbirato DS, Ramos RT, Cantisano MH. Regression of major recurrent aphthous ulcerations using a combination of intralesional corticosteroids and levamisole: a case report. Clinics. 2010;65(6):650-652.
|
RAS |
Betamethasone dipropionate+ disodiumphosphate |
5 mg/mL + 2 mg/mL |
1 |
- |
partial regression in first week. No recurrence in 6 months |
6 m |
None |
Ohbayashi et al., 2007Ohbayashi Y, Imataki O, Higuchi A, Miyake M, Ohue Y, Ohnishi H. Topical steroid injection for refractory oral chronic graft-versus-host disease. [Rinsho ketsueki]. Jap J Clin Hematol. 2007;48(11):1508-1510.
|
GVHD |
0.2% dexamethasone |
0.5 mg/cm2
|
1 |
- |
drastically improving |
- |
None |
De Oliveira et al., 2011De Oliveira MA, Martins E Martins F, Wang Q, Sonis S, Demetri G, George S, Butrynski J, Treister NS. Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral oncol. 2011;47(10):998-1003.
|
mTOR inhibitor stomatitis |
Triamcinolone 40 mg/mL (4 case clobetasol gel 0.05% |
8 to 24 mg |
1-9 |
biweekly |
drastically improving |
- |
None |
Villa et al., 2015Villa A, Aboalela A, Luskin KA, Cutler CS, Sonis ST, Woo SB, Peterson DE, Treister NS. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(3):503-508.
|
mTOR inhibitor stomatitis |
Triamcinolone acetonide |
- |
1-4 |
Weekly (4-15d) |
immediate symptomatic improvement, complete resolution 2 to 70 days |
- |
None |
Xia et al., 2006Xia J, Li C, Hong Y, Yang L, Huang Y, Cheng B. Short-term clinical evaluation of intralesional triamcinolone acetonide injection for ulcerative oral lichen planus. J Oral Pathol Med. 2006;35(6):327-331.
|
Ulcerative OLP |
Triamcinolone (40 mg/mL |
0/5 mL |
1 and 2 |
biweek |
Relief of sign & symptoms and reduction in size |
4 week |
None |
Lee et al., 2013Lee YC, Shin SY, Kim SW, Eun YG. Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. Otolaryngol Head Neck Surg. 2013;148(3):443-9.
|
OLP |
(40 mg/mL) Triamcinolone acetonide |
0.5 mL |
5 |
4 weekly and 1 biweekly |
significantly improve in pain and burning mouth |
1 y |
cushingoid features. |
Liu et al., 2013Liu C, Xie B, Yang Y, Lin D, Wang C, Lin M, Ge L, Zhou H. Efficacy of intralesional betamethasone for erosive oral lichen planus and evaluation of recurrence: a randomized, controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):584-90.
|
OLP |
Betamethasone Triamcinolone |
1.4 mg 8 mg |
2 |
weekly |
Betamethasone wes better than triamcinolone |
3m |
None |
Borahan, Fisekcioglu, Alpay, 2014Borahan MO, Fisekcioglu E, Alpay MS. A complication after intralesional methylprednisolone acetate application to oral mucosa: A case report. Balk J Dent Med 2014;18:154-156.
|
Erosive OLP |
Methylprednisolone acetate |
0.1 cc |
5 |
biweekly |
significantly improvement |
|
Abscess formation Mucosal atrophy |
Metwalli et al., 2018Metwalli MI, Marei AM, Toama MA, Soliman MI, Fawzy MM. Bacillus Calmette-Guerin polysaccharide nucleic acid extract versus triamcinolone acetonide intralesional injection in the treatment of oral lichen planus: a comparative study. Egyptian J Dermatol Venerol. 2018;38(1):1-11.
|
OLP |
Triamcinolone acetonide |
20 mg/mL |
2 |
weekly |
significantly improvement but no statistically significant differences with BCG-PSN |
2 w |
2 case atrophy and persistent \ erythema |
Tilakaratne, 2016Tilakaratne WM, Ekanayaka RP, Herath M, Jayasinghe RD, Sitheeque M, Amarasinghe H. Intralesional corticosteroids as a treatment for restricted mouth opening in oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):224-31.
|
OSF |
Methylprednisolone |
40 mg |
6 |
monthly |
improving mouth opening |
1 y |
None |
Singh, 2014Singh D, Shashikanth MC, Misra N, Agrawal S. Lycopene and intralesional betamethasone injections in the management of oral submucous fibrosis. J Indian Acad Oral Med Radiol 2014;26(3):264-8.
|
OSF |
Betamethasone Lycopene |
4 mg |
16 |
Twice weekly |
Lycopene is better than betamethasone. |
4 m |
None |
James, 2015James L, Shetty A, Rishi D, Abraham M. Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in grade III oral submucous fibrosis: A retrospective study. J Int Oral Health. 2015;7(8):82-5.
|
OSF |
Dexamethasone+ Hyaluronidase + Lignocaine HCL |
1.5 mL 1500 IU 0.5 mL |
2 |
biweekly |
Improvement in mouth opening Reduction in burning sensation and ulceration |
9 m |
None |
Kumar, 2007Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(2):207-13.
|
OSF |
Betamethasonee + Lycopene |
2 1-mL ampules of 4 mg |
4 |
biweekly |
Mouth opening was increased more in steroid group. |
6 m |
None |
Singh, 2010Singh M, Niranjan HS, Mehrotra R, Sharma D, Gupta SC. Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. ndian J Med Res. 2010;131:665-9.
|
OSF |
Hydrocortisone acetate+ Hyaluronidase
Triamcinolone+ Hyaluronidase |
1.5 mL 1500 IU
10 mg 1500 IU |
22
11 |
Weekl
Biweekly |
Biweekly injections was more convenient because of number of visits and cost |
3 m |
None |
Nguyen, Ahmed, 2014Nguyen T, Ahmed AR. Pemphigus vulgaris localized to the tongue. J Dermatol Case Rep. 2014;8(2):55-57.
|
Pemphigus vulgaris |
Triamcinolone acetonidein 2% xylocaine |
10-15 mg |
4 |
Every three weeks |
lesions resolved within five to sevendays. |
18 m |
None |
Abbas et al., 2014Abbas Z, Safaie Naraghi Z, Behrangi E. Pemphigus vulgaris presented with cheilitis. Case Rep Dermatol Med. 2014;2014:147197.
|
Pemphigus vulgaris |
Triamcinolone + 2gcellcept |
10 mg/mL +daily |
2 |
|
Resolving within 2 months. |
1 year |
None |
Mignogna et al., 2010Mignogna M, Fortuna G, Leuci S, Adamo D, Dell’Aversana Orabona G, Ruoppo E. Adjuvant triamcinolone acetonide injections in oro-pharyngeal pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2010;24(10):1157-1165.
|
Pemphigus vulgaris |
Triamcinolone acetonide |
40 mg ⁄mL diluted 2 : 1 with saline (i.e. 25 mg ⁄mL) per four lesions |
2-8 |
weekly |
Reducing time of remission and total number of corticosteroids |
5.3 years |
Gingival pellets and Candidiasis |
Kalinska-Bienias et al., 2016Kalinska-Bienias A, Kalowska M, Kwiek B, Jakubowska B, Ishii N, Hashimoto T, Kowalewski C, Wozniak K. Efficacy and safety of perilesional/intralesional triamcinolone injections in oral mucous membrane pemphigoid. Br J Dermatol. 2016;174(2):436-8.
|
MMP |
Triamcinolone |
0.3 - 2 mL per erosion |
2- 18 |
- |
remission |
6-10 m |
None |
Leroux et al., 2011Leroux E, Valade D, Taifas I, Vicaut E, Chagnon M, Roos C, Ducros A. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2011;10(10):891-7.
|
Cluster headache |
Cortivazol+ verapamil |
3.75 mg in 1.5 mL |
3 |
48-72 hours |
Rapidly relief was seen in steroid group |
3-11 m |
None |
Gaul et al., 2016Gaul C, Roguski J, Dresler T, Abbas H, Totzeck A, Görlinger K, Diener H-C, Weber R. Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study. Cephalalgia. 2017;37(9):873-880.
|
Cluster headache |
Triamcinolone and bupivacaine |
10 mg |
1 |
- |
Steroid ijectiois an easy, safe and effective |
60 days |
None |
Sinha R, 2016Sinha R, Sarkar S, Khaitan T, Kabiraj A, Maji A. Nonsurgical management of oral mucocele by intralesional corticosteroid therapy. Int J Dent. 2016;2016:2896748.
|
Mucocele |
Betamethason 4 mg/ mL |
1 mL |
2-4 |
weekly |
18 case complete resolved, 2 case Reduced in size |
6 m |
Mild discomfort |
Mortazavi et al., 2017Mortazavi H, Baharvand M, Alirezaei S, Noor-Mohammadi R. Combination therapy in a large lower lip mucocele: a non-invasive recommended technique. Dental Hypotheses. 2014;5(3):127-29.
|
M ucocele |
dexamethasone (8 mg/2 mL + silk sutures ) |
|
3 |
weekly |
Complete healing |
6 m |
None |
Baharvand et al., 2014Baharvand M, Sabounchi S, Mortazavi H. Treatment of labial mucocele by intralesional injection of dexamethasone: case series. J Dent Mater Tech. 2014;3(3):128-133.
|
Mucocele |
8 mg/mL Dexamethasone |
1 mL |
3 |
weekly |
7 case complete resolved 2 case Reduced in size |
(6-20 m) |
Mild discomfort |
Mignogna et al., 2004Mignogna M, Fedele S, Russo LL, Adamo D, Satriano R. Effectiveness of small-volume, intralesional, delayed-release triamcinolone injections in orofacial granulomatosis: a pilot study. J Am Acad Dermatol. 2004;51(2):265-268.
|
orofacial granulomatosis |
Triamcinolone 40 mg/mL |
1 mL (4 mg) |
2-3 |
weekly |
lip swellingsettle in all patients with 3 recurrences |
3-30 m |
Hypopigmentation of the upper lip skin |
Ravindran, Karunakaran, 2013Ravindran R, Karunakaran A. Idiopathic orofacial granulomatosis with varied clinical presentation. Case Rep Dent. 2013;2013:701749.
|
orofacial granulomatosis |
Triamcinolone acetonide |
- |
2 |
biweekly |
Improvement with no recurrences |
1 y |
None |
van der Waal et al., 2002Van Der Waal RI, Schulten EA, Van Der Meij EH, Van De Scheur MR, Starink TM, Van Der Waal I. Cheilitis granulomatosa: overview of 13 patients with long-term follow-up-results of management. Int J Dermatol. 2002;41(4):225-229.
|
orofacial granulomatosis |
Triamcinolone acetonide |
|
Within 2-6 m |
biweekly to monthly |
Patients responded to ICSI. |
8.2 y |
None |
Yang et al., 2005Yang JH, Lee UH, Jang SJ, Choi JC. Plasma cell cheilitis treated with intralesional injection of corticosteroids. J Dermatol. 2005;32(12):987-990.
|
Plasma Cell Cheilitis |
Triamcinolone acetonide |
5.0-4.0 mg/mL |
2-4 |
biweekly |
lesions healedcompletely |
- |
None |
Tseng et al., 2008Tseng JP, Cheng CJ, Lee WR, Wang KH. Plasma-cell cheilitis: successful treatment with intralesional injections of corticosteroids. Clin Exp Dermatol. 2009;34(2):174-177.
|
Plasma Cell Cheilitis |
Triamcinolone acetonide (2.5 mg ⁄ mL ). |
0.1 mL |
2 |
biweekly |
healedcompletely |
1 y |
None |
Kaur et al., 2001Kaur C, Thami G, Sarkar R, Kanwar A. Plasma cell mucositis. J Eur Acad Dermatol Venereol. 2001;15(6):566-7.
|
Plasma Cell Cheilitis |
triamcinolone acetonide 10 mg/mL |
|
3 |
biweekly |
healedcompletely |
3 m |
None |
Ebrahimi, Nader, Kendall, 2016Ebrahimi A, Nader A, Kendall M. (389) Treatment of refractory trigeminal neuralgia caused by head and neck radiation with ultrasound guided trigeminal nerve block. J Pain. 2016;17(4):S72.
|
trigeminal neuralgia |
|
|
2 |
|
excellent pain relief |
|
|
Elshiek, Amr, 2016Elsheikh N, Amr YM. Calcitonin as an additive to local anesthetic and steroid injection using a modified coronoid approach in trigeminal neuralgia. Pain Physic. 2016;19(7):457-64.
|
trigeminal neuralgia |
Methylprednisolone |
40 mg |
1 |
- |
Calcitonin was better than steroid |
2w to 12m |
None |
Hannon, 1983Hannon SM, Pickett AB, Frost JM. Foreign-body (silica) granuloma of the lip. J Oral Maxillofac Surg. 1983 Jul;41(7):470-2.
|
Foreign-body Granuloma |
Triamcinolone diacetate |
0.7 mL and 0.5 mL |
2 |
biweekly |
healed completely |
6 w |
None |
Anjomshoaa et al., 2013Anjomshoaa I, Bulford LA, Dym H, Woo S.-B. Florid follicular lymphoid hyperplasia of the hard palatal mucosa managed with intralesional steroids: a case report and review of the literature. J Oral Maxillofac Surg. 2013;71(7):1202-8.
|
Follicular Lymphoid Hyperplasia |
Triamcinolone acetonide |
40 mg in 1 mL |
4 |
weekly |
completely resolved . |
7 m |
none |